Literature DB >> 8345427

Lysinuric protein intolerance with chronic interstitial lung disease and pulmonary cholesterol granulomas at onset.

E Kerem1, O N Elpelg, R S Shalev, E Rosenman, Y Bar Ziv, D Branski.   

Abstract

Hyperammonemia and encephalopathy developed in an 11-year-old girl with chronic interstitial lung disease and cholesterol casts in her lung biopsy specimen. She had decreased plasma levels of ornithine, lysine, and arginine and excessive urinary excretion of lysine and arginine, consistent with the diagnosis of lysinuric protein intolerance. Analysis of plasma and urinary amino acids should be considered in the diagnostic evaluation of patients with interstitial lung disease of uncertain origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345427     DOI: 10.1016/s0022-3476(05)81703-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Intravenous immune globulin in lysinuric protein intolerance.

Authors:  C Dionisi-Vici; L De Felice; M el Hachem; S Bottero; C Rizzo; A Paoloni; B Goffredo; G Sabetta; M Caniglia
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

2.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Lysinuric protein intolerance presenting as coma in a middle-aged man.

Authors:  M Gare; M Shalit; A Gutman
Journal:  West J Med       Date:  1996-10

4.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

5.  Lung involvement in children with lysinuric protein intolerance.

Authors:  Sarah Valimahamed-Mitha; Laureline Berteloot; Héloise Ducoin; Chris Ottolenghi; Pascale de Lonlay; Jacques de Blic
Journal:  J Inherit Metab Dis       Date:  2014-10-22       Impact factor: 4.982

6.  Genetic Basis of Children's Interstitial Lung Disease.

Authors:  Lawrence M Nogee
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 7.  Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases.

Authors:  Joanna Y Wang; Lisa R Young
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

8.  Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report.

Authors:  Michele Ceruti; Giuseppe Rodi; Giulia M Stella; Andrea Adami; Antonia Bolongaro; Aldo Baritussio; Ernesto Pozzi; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2007-03-26       Impact factor: 4.123

9.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

10.  Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Josefina Longeri Contreras; Mabel A Ladino; Katherine Aránguiz; Gonzalo P Mendez; Zeynep Coban-Akdemir; Bo Yuan; Richard A Gibbs; Lindsay C Burrage; James R Lupski; Ivan K Chinn; Tiphanie P Vogel; Jordan S Orange; M Cecilia Poli
Journal:  Front Pediatr       Date:  2021-05-20       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.